Darya-Varia Laboratoria Tbk PT
dr. Ian Martin Wibawa Kloer was first appointed as Vice President Director of Darya-Varia on EGMS, 20 October 2020. He obtained his Bachelor’s degree in Medicine from Trisakti University in 1998 and his Bachelor’s degree in Public Health from the University of Indonesia in 2001. He also took his oath as a Medical Doctor in 2001. Starting his career in PT Panarub Industry as HSE & Labor Practice Manager, and then joined in Mega Lifesciences PTY. LTD. as Ethical Products Brand Manager. He also served as Business Manager in PT Ferron Par Pharmaceuticals (Dexa Medica Group). Before joining Darya-Varia, he worked in PT Fresenius Kabi Indonesia as Vice President Transfusion and Cell Technologies (TCT), for the cluster of Indonesia, Malaysia, Singapore dan the Philippines.
This person is not in the org chart
This person is not in any offices
Darya-Varia Laboratoria Tbk PT
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is an Indonesia-based company operating in the pharmaceutical industry. The Company's major business activities are classified into three business segments: Prescription drugs, Consumer health products and Export and toll manufacturing services. Darya-Varia's leading products under the Prescription drugs segment are namely Mediamer B6 and Obimin - AF, drugs under woman health segment; Thrombo Aspilets, a cardiac medication, and Trifluoperazine, a central nervous system agent. Its products under the Consumer health products segment include Enervon-C, a health supplement and Decolgen FX Tablet, a flu treatment medicine. Other products of the Company include medicated plasters, lotions and creams.